The anti-amyloid antibodies of the 2020s, the first drugs ever to bend the course of the disease at all, did it the hard way: enormous multi-country trials with pre-specified cognitive endpoints, full publication in the New England Journal of Medicine and JAMA , and a brutal public fight over whether their modest benefit was even worth the brain-swelling risk
We pass those savings directly to you
Wegovy is different
Protein needs vary by patient based on body size, medical history, kidney function, age, activity level, and body composition goals
Edrington TS, Harvey RB, Farrington LA, Nisbet DJ
Previously: First-ever randomized trial of Ozempic for alcohol use disorder shows significant reductions in drinking Randomized Controlled Trial for Liraglutide and Opioid Use Disorder New results for opioid use disorder were recently presented at the American Association for the Advancement of Science conference by Penn researchers
